Therefore, we believe that further study on the upstream and downstream of ISL1, such as epigenetic regulatory factors, gene reprogramming process of proliferation and differentiation, or cooperation with other known oncogenes, etc. is helpful to better understand the pathogenesis of NB and find novel therapeutic targets. The gene discussed is ISL1; the disease is neuroblastoma.